- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Uruguay Faces Cannabis Shortage Through First Week of Legalization
Uruguay sees supply shortage sin cannabis following its official legalization for recreational use in addition to medical.
Demand has met and surpassed supply for the recently legalized adult cannabis market in Uruguay.
It took all but one day for the cannabis supply to run out in Uruguay. According to local press, on the first day of full legalized adult-use consumers were left with nothing in the capital city of Montevideo, which hosts four pharmacies allowed to sell cannabis. There are 16 total licensed pharmacies in all Uruguay.
“I was left with no stock,” Sebastian Scaffo, the owner of one of the four licensed pharmacies in Montevideo told La Nacion. “[I] couldn’t call to get my stock replenished.”
Pharmacies in the capital had to request more product almost immediately
Ecos reported nearly 35 kilograms have been sold through the rigorous system in Uruguay since legalization kicked off on July 19.
“After a week of sales of cannabis in the country, the four pharmacies in Montevideo had to replenish for a third time,” the online website wrote.
According to Ecos, between 10 and 12 new pharmacies have shown interest in applying for the sale license. The number of licenses for people also saw an increase following the beginning of sales, up to the first day of legal sales 6,797 people had registered, in the past week, 1,200 applied.
On an account of the first day of sales in the country, El Observador reported the much anticipated day saw a variety of issues for consumers including long lineups and faulty computer recognition systems, which forced pharmacies to turn away people for whom the system didn’t recognize, yet claimed to have registered with the government in advance of the date.
“According to El Pais, cannabis ran out in the course of the day for all four licensed pharmacies in Montevideo,” El Observador wrote.
The restrictions put in place for the cannabis market in Uruguay, limit consumers to buy a monthly maximum of 40 grams. Currently, vendors are only allowed to sell 5-gram container bags, priced at $1.30 per gram. However, CNBC reported 10-gram containers are expected.
I think the situation in Uruguay is going to be heavily watched, it won’t be ignored,” Emilio Ruchansky editor of THC magazine, a cannabis lifestyle and culture publication told Resumen Del Sur.
Investor Takeaway
The situation in Uruguay has been closely followed by the Canadian market as it hopes to also legalize the sale of cannabis next year. However, the shortage experienced in the country is another example of a rush boom through legalization, a similar shortage is expected in Canada.
Don’t forget to follow us @INN_LifeScience and @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.